Royal Bank Of Canada Seagen Inc. Call Options Transaction History

Royal Bank Of Canada

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $514,323 - $678,755	-4,300 Reduced 6.14%	65,700 $9.46 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $1.17 Million - $1.39 Million	-8,200 Reduced 10.49%	70,000 $11.9 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $10.6 Million - $12.6 Million	78,200 New	78,200 $12.3 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.